Telix share price set to climb on revenue guidance
MELBOURNE: Cancer diagnostics specialist Telix Pharmaceuticals has upgraded its full-year revenue forecast following a strong
MELBOURNE: Cancer diagnostics specialist Telix Pharmaceuticals has upgraded its full-year revenue forecast following a strong